Eric Fink Global Blood Therapeutics, Inc. (GBT) insider trading activity

Eric Fink is Chief Human Resources Officer of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 5,161 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on May 10, 2021, when has been sold 500 shares (Common Stock) at a price of $37.96 per share, resulting in proceeds of $18,980. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.16K

0% 3M change

0% 12M change

Total Value Held $0

Eric Fink Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 10 2021	BUY Open market or private purchase	$18,980 $37.96 p/Share	500 Added 8.83%	5,161 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$38,208 $44.48 p/Share	859 Reduced 15.56%	4,661 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	-	3,125 Added 36.15%	5,520 Common Stock
Feb 01 2021	SELL Payment of exercise price or tax liability	$46,867 $49.49 p/Share	947 Reduced 28.34%	2,395 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	-	3,020 Added 47.47%	3,342 Common Stock
Feb 01 2021	BUY Grant, award, or other acquisition	$13,717 $42.6 p/Share	322 Added 50.0%	322 Common Stock
Oct 05 2020	SELL Open market or private sale	$271,920 $60.0 p/Share	4,532 Reduced 100.0%	0 Common Stock

Eric Fink

Chief Human Resources Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBT shares.

Notify only if

Value

Insider Trading

Get notified when an Global Blood Therapeutics, Inc. insider buys or sells GBT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Global Blood Therapeutics, Inc.

Track Activities on GBT

Account